Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_001319206.4(MEF2A):c.149G>C(p.Ser50Thr) variant causes a missense change. The variant allele was found at a frequency of 0.00000274 in 1,461,348 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
MEF2A (HGNC:6993): (myocyte enhancer factor 2A) The protein encoded by this gene is a DNA-binding transcription factor that activates many muscle-specific, growth factor-induced, and stress-induced genes. The encoded protein can act as a homodimer or as a heterodimer and is involved in several cellular processes, including muscle development, neuronal differentiation, cell growth control, and apoptosis. Defects in this gene could be a cause of autosomal dominant coronary artery disease 1 with myocardial infarction (ADCAD1). Several transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Jan 2010]
Review Status: criteria provided, single submitter
Collection Method: clinical testing
The c.149G>C (p.S50T) alteration is located in exon 4 (coding exon 2) of the MEF2A gene. This alteration results from a G to C substitution at nucleotide position 149, causing the serine (S) at amino acid position 50 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Loss of catalytic residue at S50 (P = 0.0573);Loss of catalytic residue at S50 (P = 0.0573);Loss of catalytic residue at S50 (P = 0.0573);Loss of catalytic residue at S50 (P = 0.0573);Loss of catalytic residue at S50 (P = 0.0573);Loss of catalytic residue at S50 (P = 0.0573);